These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24588719)

  • 1. A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis.
    Fujimoto M; Tsuneyama K; Nakanishi Y; Salunga TL; Nomoto K; Sasaki Y; Iizuka S; Nagata M; Suzuki W; Shimada T; Aburada M; Shimada Y; Gershwin ME; Selmi C
    J Med Food; 2014 Mar; 17(3):374-83. PubMed ID: 24588719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
    Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia.
    Nakanishi Y; Tsuneyama K; Fujimoto M; Salunga TL; Nomoto K; An JL; Takano Y; Iizuka S; Nagata M; Suzuki W; Shimada T; Aburada M; Nakano M; Selmi C; Gershwin ME
    J Autoimmun; 2008; 30(1-2):42-50. PubMed ID: 18178378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
    Belemets N; Kobyliak N; Virchenko O; Falalyeyeva T; Olena T; Bodnar P; Savchuk O; Galenova T; Caprnda M; Rodrigo L; Skladany L; Delev D; Opatrilova R; Kruzliak P; Beregova T; Ostapchenko L
    Biomed Pharmacother; 2017 Apr; 88():267-276. PubMed ID: 28110193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
    Coelho CFF; França LM; Nascimento JR; Dos Santos AM; Azevedo-Santos APS; Nascimento FRF; Paes AMA
    J Dev Orig Health Dis; 2019 Apr; 10(2):188-195. PubMed ID: 29855396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice.
    Sasaki Y; Suzuki W; Shimada T; Iizuka S; Nakamura S; Nagata M; Fujimoto M; Tsuneyama K; Hokao R; Miyamoto K; Aburada M
    Life Sci; 2009 Sep; 85(13-14):490-8. PubMed ID: 19683013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
    Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
    Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite.
    Hermanussen M; García AP; Sunder M; Voigt M; Salazar V; Tresguerres JA
    Eur J Clin Nutr; 2006 Jan; 60(1):25-31. PubMed ID: 16132059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
    J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
    Nakano T; Cheng YF; Lai CY; Hsu LW; Chang YC; Deng JY; Huang YZ; Honda H; Chen KD; Wang CC; Chiu KW; Jawan B; Eng HL; Goto S; Chen CL
    J Hepatol; 2011 Aug; 55(2):415-25. PubMed ID: 21184788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
    Yamazaki Y; Usui I; Kanatani Y; Matsuya Y; Tsuneyama K; Fujisaka S; Bukhari A; Suzuki H; Senda S; Imanishi S; Hirata K; Ishiki M; Hayashi R; Urakaze M; Nemoto H; Kobayashi M; Tobe K
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1179-86. PubMed ID: 19724016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
    Miyazaki T; Shirakami Y; Kubota M; Ideta T; Kochi T; Sakai H; Tanaka T; Moriwaki H; Shimizu M
    Oncotarget; 2016 Mar; 7(9):10448-58. PubMed ID: 26871288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
    Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of diet and nutrient composition in nonalcoholic Fatty liver disease.
    McCarthy EM; Rinella ME
    J Acad Nutr Diet; 2012 Mar; 112(3):401-9. PubMed ID: 22717200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosodium glutamate versus diet induced obesity in pregnant rats and their offspring.
    Afifi MM; Abbas AM
    Acta Physiol Hung; 2011 Jun; 98(2):177-88. PubMed ID: 21616776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on "A dietary restriction influences the progression but not the initiation of MSG-induced nonalcoholic steatohepatitis".
    Rogers MD
    J Med Food; 2015 Feb; 18(2):145-6. PubMed ID: 25587736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.